Accessibility Menu
Medifast Stock Quote

Medifast (NYSE: MED)

$12.64
(-1.8%)
-0.23
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$12.64
Daily Change
(-1.8%) $0.23
Day's Range
$12.53 - $13.05
Previous Close
$12.64
Open
$12.85
Beta
0.89
Volume
147,837
Average Volume
164,885
Market Cap
138.9M
Market Cap / Employee
$12.64M
52wk Range
$11.57 - $21.98
Revenue
-
Gross Margin
0.74%
Dividend Yield
N/A
EPS
$0.33
CAPs Rating
-
Industry
Personal Products

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Medifast Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MED-26.89%-90.41%-37.43%+209%
S&P+14.5%+93.32%+14.09%+1,330%

Medifast Company Info

Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm’s product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$105.56M-37.4%
Gross Profit$76.64M-37.9%
Gross Margin72.61%-0.6%
Market Cap$154.42M-35.3%
Market Cap / Employee$0.31M0.0%
Employees504-20.5%
Net Income$2.48M130.4%
EBITDA$2.98M161.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$101.69M-5.9%
Inventory30.2-23.7%

Liabilities

Q2 2025YOY Change
Long Term Debt$7.14M-45.3%
Short Term Debt$5.92M-1.8%

Ratios

Q2 2025YOY Change
Return On Assets1.29%-8.3%
Return On Invested Capital52.55%-13.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$4.76M-142.7%
Operating Free Cash Flow-$3.38M-125.8%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q2 2025YoY Change
Price to Earnings8.1428.6493.1342.63589.73%
Price to Book1.020.930.700.73-35.29%
Price to Sales0.310.320.270.324.38%
Price to Tangible Book Value1.020.930.700.73-35.29%
Price to Free Cash Flow TTM13.5113.8711.8711.12-20.24%
Enterprise Value to EBITDA10.885.51-1.191.94-109.91%
Free Cash Flow Yield7.4%7.2%8.4%9.0%25.37%
Return on Equity3.7%1.0%-3.3%1.7%-88.49%
Total Debt$17.63M$16.13M$14.61M$13.07M-31.58%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.